A drug intended for to postmenopausal women and designed to treat pain during intercourse, Osphena, will soon hit the market in the United States.
This “Viagra for women” is not the first to go on sale, explains the Slate news site, but it is the only one to have been approved in early April by the US Food and Drug Administration. According to the laboratory that markets the drug, Shionogi, half of postmenopausal Americans have need to regain their libido.
This argument has been harshly criticized by specialists and experts who fight against the message “menopause is a disease” and accuse the pharmaceutical company of spreading false information. “According to obstetrician-gynecologist and bioethicist Lorena Wissner-Greene, only 10% of women who have gone through menopause actually need treatment,” Slate reports.
Among other things, the women’s blog Jezebel specifies that women who tested the drug, before it was approved, would have been 14 times more prone to urinary tract infections. Enough to cool down adventurous women in search of a remedy to boost their sexuality.
